Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report

Herein, we present the first described hereditary hemorrhagic telangiectasia (HHT) patient treated with aflibercept for severe GI involvement after tachyphylaxis to bevacizumab, with promising results. HHT is a rare genetic disease characterized by systemic vascular malformations. Gastrointestinal t...

Descripción completa

Detalles Bibliográficos
Autores principales: Villanueva, Bernat, Iriarte, Adriana, Torres-Iglesias, Raquel, Muñoz Bolaño, Miriam, Cerdà, Pau, Riera-Mestre, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534796/
https://www.ncbi.nlm.nih.gov/pubmed/37763652
http://dx.doi.org/10.3390/medicina59091533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534796/
https://www.ncbi.nlm.nih.gov/pubmed/37763652
http://dx.doi.org/10.3390/medicina59091533

Ejemplares similares